TrialInvestigational new drugs2022

Anlotinib plus etoposide and cisplatin/carboplatin as first-line therapy for extensive-stage small cell lung cancer (ES-SCLC): a single-arm, phase II study.

Tiandong Kong et al.PubMed ↗Publisher ↗

No numbers read from the abstract.